RNAC · Cartesian Therapeutics, Inc.
$8.13
+0.00 (+0.00%)
At close · Jul 22
Market Cap
$238.87M
Shares
29.38M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Carsten Brunn | CEO | $4,329,868 |
| Metin Kurtoglu | CTO | $2,474,034 |
| Christopher Jewell | Chief Scientific Officer | $2,015,707 |
| Blaine Davis | CFO | $1,949,927 |
| Milos Miljkovic | Chief Medical Officer | $1,657,535 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Carsten Brunn | CEO | $7,314,211 |
| Blaine Davis | CFO | $3,971,412 |
| Metin Kurtoglu | CTO | $2,713,064 |
| Christopher Jewell | Chief Scientific Officer | $1,687,754 |
| Milos Miljkovic | Chief Medical Officer | $1,349,018 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Carsten Brunn | CEO | $6,111,883 |
| Peter G. Traber | Chief Medical Officer | $3,780,920 |
| Lloyd Johnston | Chief Operations Officer | $2,697,590 |
| Blaine Davis | CFO | $2,494,759 |
| Metin Kurtoglu | CTO | $71,243 |
| Chris Jewell | Chief Scientific Officer | $53,100 |
| Christopher Jewell | Chief Scientific Officer | $53,100 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Carsten Brunn | CEO | $4,292,242 |
| Peter G. Traber | Chief Medical Officer | $2,003,983 |
| Kevin Tan | CFO | $1,688,429 |
| Takashi Kei Kishimoto | Chief Scientific Officer | $1,684,353 |
| Lloyd Johnston | Chief Operations Officer | $1,674,359 |
| Blaine Davis | CFO | $1,263,706 |
| Metin Kurtoglu | CTO | — |
| Chris Jewell | Chief Scientific Officer | — |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Carsten Brunn | CEO | $3,671,395 |
| Kevin Tan | CFO | $2,601,622 |
| Peter G. Traber | Chief Medical Officer | $1,600,685 |
| Takashi Kei Kishimoto | Chief Scientific Officer | $1,306,675 |
| Lloyd Johnston | Chief Operations Officer | $1,304,845 |
| Bradford D. Dahms | CFO | $868,053 |
| Ann K. Donohue | C.P.A. VP, Finance and Corporate Controller, Principal Financial and Accounting Officer | $361,493 |
| Blaine Davis | CFO | — |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Carsten Brunn | CEO | $2,095,347 |
| Peter G. Traber | Chief Medical Officer | $1,512,857 |
| Bradford D. Dahms | CFO | $959,356 |
| Lloyd Johnston | Chief Operations Officer | $889,306 |
| Takashi Kei Kishimoto | Chief Scientific Officer | $807,333 |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| Carsten Brunn | CEO | $1,986,495 |
| Elona Kogan | General Counsel | $1,359,486 |
| Stephen Smolinski | Chief Commercial Officer | $964,635 |
| Bradford D. Dahms | CFO | $768,604 |
Fiscal 2018
| Executive | Role | Total |
|---|---|---|
| Carsten Brunn | CEO | $5,605,148 |
| Stephen Smolinski | Chief Commercial Officer | $1,236,950 |